Quality Assessment and Publication Bias:
We conducted a rigorous quality assessment of the included trials using
the Cochrane risk of bias tool, identifying trials of moderate-to-high
quality. Notably, our results remained unaffected by any potential
publication bias, as demonstrated by the symmetrical distribution of
studies on each side of the vertical axis in the funnel plots of the
primary outcomes.